Max Healthcare Institute Ltd Nine-Monthly Results: Standalone & Consolidated Reports

Nine Monthly Results

Results Snapshot

Figures in Cr

Consolidate Nine Monthly Results

Dec'25

Dec'24

Dec'23

Dec'22

Dec'21

Dec'20

Dec'19

Net Sales

6,230.56

5,118.72

3,983.12

3,345.17

2,994.19

1,702.81

811.17

Other Operating Income

0.00

Total Operating income

6,230.56

5,118.72

3,983.12

3,345.17

2,994.19

1,702.81

811.17

Raw Material Cost

1,365.44

1,086.27

821.63

683.67

735.44

409.16

165.27

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

-14.96

-18.65

1.29

-7.73

-12.36

9.28

-2.50

Employee Cost

1,016.85

858.42

692.56

599.47

590.57

403.93

182.04

Power Cost

0.00

Manufacturing Expenses

1,321.11

1,068.36

824.34

724.31

590.59

365.60

184.66

Selling and Distribution Expenses

0.00

Other Expenses

905.72

787.24

532.71

448.18

359.35

292.14

207.78

Total Expenditure (Excl Depreciation)

4,594.16

3,781.64

2,872.53

2,447.90

2,263.59

1,480.11

737.25

Operating Profit (PBDIT) excl Other Income

1,636.40

1,337.08

1,110.59

897.27

730.60

222.70

73.92

Other Income

114.79

108.82

132.82

101.94

104.35

99.15

20.98

Operating Profit (PBDIT)

1,751.19

1,445.90

1,243.41

999.21

834.95

321.85

94.90

Interest

168.44

109.81

39.16

64.33

78.72

134.74

58.03

Exceptional Items

-48.24

-73.63

0.00

-9.03

-233.70

0.00

Gross Profit (PBDT)

1,534.51

1,262.46

1,204.25

934.88

747.20

-46.59

36.87

Depreciation

323.51

258.59

174.66

171.84

162.69

131.26

33.88

Profit Before Tax

1,211.00

1,003.87

1,029.59

763.04

584.51

-177.85

2.99

Tax

110.81

246.99

223.49

-89.55

103.19

9.88

-0.13

Provisions and contingencies

0.00

Profit After Tax

1,100.19

756.88

806.10

852.59

481.32

-187.73

3.12

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

1,100.19

756.88

806.10

852.59

481.32

-187.73

3.12

Share in Profit of Associates

0.00

-23.05

2.72

Minority Interest

0.00

Other related items

0.00

Consolidated Net Profit

1,100.19

756.88

806.10

852.59

481.32

-210.78

5.84

Equity Capital

972.77

972.13

971.83

970.72

904.53

537.24

Face Value

10.0

Reserves

0.00

Diluted Earnings per share

3.09

2.44

2.97

2.29

1.96

1.0

-0.03

Operating Profit Margin (Excl OI)

26.26%

26.12%

27.88%

26.82%

24.4%

13.08%

9.11%

Gross Profit Margin

24.63%

24.66%

30.23%

27.95%

24.95%

-2.74%

4.55%

PAT Margin

17.66%

14.79%

20.24%

25.49%

16.08%

-11.02%

0.38%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Nine Monthly Analysis Highlights

Net Sales

YoY Growth in nine months ended Dec 2025 is 21.72% vs 28.51% in Dec 2024

Consolidate Net Profit

YoY Growth in nine months ended Dec 2025 is 45.36% vs -6.11% in Dec 2024

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2025 is 22.39% vs 20.39% in Dec 2024

Interest

YoY Growth in nine months ended Dec 2025 is 53.39% vs 180.41% in Dec 2024

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2025 has improved from Dec 2024

Compare Nine Monthly Results Of Max Healthcare With

Select Peers

Figures in Cr

Consolidate Nine Monthly Results

Change(INR)

Change(%)

Net Sales

6,230.56

18,623.00

-12,392.44

-66.54%

Other Operating Income

0.00

Total Operating income

6,230.56

18,623.00

-12,392.44

-66.54%

Raw Material Cost

1,365.44

2,263.40

-897.96

-39.67%

Purchase of Finished goods

0.00

7,443.30

-7,443.30

-100.00%

(Increase) / Decrease In Stocks

-14.96

-33.10

18.14

54.80%

Employee Cost

1,016.85

2,228.30

-1,211.45

-54.37%

Power Cost

0.00

Manufacturing Expenses

1,321.11

0.00

1,321.11

Selling and Distribution Expenses

0.00

Other Expenses

905.72

3,962.80

-3,057.08

-77.14%

Total Expenditure (Excl Depreciation)

4,594.16

15,864.70

-11,270.54

-71.04%

Operating Profit (PBDIT) excl Other Income

1,636.40

2,758.30

-1,121.90

-40.67%

Other Income

114.79

147.70

-32.91

-22.28%

Operating Profit (PBDIT)

1,751.19

2,906.00

-1,154.81

-39.74%

Interest

168.44

330.50

-162.06

-49.03%

Exceptional Items

-48.24

-19.20

-29.04

-151.25%

Gross Profit (PBDT)

1,534.51

2,556.30

-1,021.79

-39.97%

Depreciation

323.51

651.70

-328.19

-50.36%

Profit Before Tax

1,211.00

1,919.50

-708.50

-36.91%

Tax

110.81

488.10

-377.29

-77.30%

Provisions and contingencies

0.00

Profit After Tax

1,100.19

1,416.50

-316.31

-22.33%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

1,100.19

1,416.50

-316.31

-22.33%

Share in Profit of Associates

0.00

34.80

-34.80

-100.00%

Minority Interest

0.00

-11.00

11.00

100.00%

Other related items

0.00

Consolidated Net Profit

1,100.19

1,412.30

-312.11

-22.10%

Equity Capital

972.77

71.90

900.87

1,252.95%

Face Value

10.00

5.00

0.00

Reserves

0.00

Gross Profit Margin

24.63%

13.73%

0.00

10.90%

PAT Margin

17.66%

7.61%

0.00

10.05%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Nine Monthly - Net Sales

Net Sales 6,230.56 Cr

in Dec 2025

Figures in Cr

YoY Growth in nine months ended Dec 2025 is 21.72% vs 28.51% in Dec 2024

Nine Monthly - Consolidate Net Profit

Consolidate Net Profit 1,100.19 Cr

in Dec 2025

Figures in Cr

YoY Growth in nine months ended Dec 2025 is 45.36% vs -6.11% in Dec 2024

Nine Monthly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 1,636.40 Cr

in Dec 2025

Figures in Cr

YoY Growth in nine months ended Dec 2025 is 22.39% vs 20.39% in Dec 2024

Nine Monthly - Interest

Interest 168.44 Cr

in Dec 2025

Figures in Cr

YoY Growth in nine months ended Dec 2025 is 53.39% vs 180.41% in Dec 2024

Nine Monthly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 26.26%

in Dec 2025

Figures in %

YoY Growth in nine months ended Dec 2025 has improved from Dec 2024